<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Garcia-Martin E</submitter><funding>FEDER funds</funding><funding>Instituto de Salud Carlos III</funding><funding>Junta de Extremadura, Mérida, Spain</funding><funding>Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Madrid, Spain</funding><pagination>15244</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9735634</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(23)</volume><pubmed_abstract>Several recent works have raised the possibility of the contribution of the lymphocyte activation gene 3 (LAG3) protein in the inflammatory processes of multiple sclerosis (MS). Results of studies on the possible association between &lt;i>LAG3&lt;/i> gene variants and the risk of MS have been inconclusive. In this study, we tried to show the possible association between the most common single nucleotide variants (SNVs) in the &lt;i>CD4&lt;/i> and &lt;i>LAG3&lt;/i> genes (these two genes are closely related) and the risk of MS in the Caucasian Spanish population. We studied the genotypes and allelic variants &lt;i>CD4 rs1922452&lt;/i>, &lt;i>CD4 rs951818&lt;/i>, and &lt;i>LAG3 rs870849&lt;/i> in 300 patients diagnosed with MS and 400 healthy patients using specific &lt;i>TaqMan&lt;/i>-based qPCR assays. We analyzed the possible influence of the genotype frequency on age at the onset of MS, the severity of MS, clinical evolutive subtypes of MS, and the &lt;i>HLADRB1*1501&lt;/i> genotype. The frequencies of the &lt;i>CD4 rs1922452&lt;/i>, &lt;i>CD4 rs951818&lt;/i>, and &lt;i>LAG3 rs870849&lt;/i> genotypes and allelic variants were not associated with the risk of MS and were unrelated to gender, age at onset and severity of MS, the clinical subtype of MS, and &lt;i>HLADRB1*1501&lt;/i> genotype. The results of the current study showed a lack of association between the &lt;i>CD4 rs1922452&lt;/i>, &lt;i>CD4 rs951818&lt;/i>, and &lt;i>LAG3 rs870849&lt;/i> SNVs and the risk of developing MS in the Caucasian Spanish population.</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Association between &lt;i>LAG3/CD4&lt;/i> Genes Variants and Risk for Multiple Sclerosis.</pubmed_title><pmcid>PMC9735634</pmcid><funding_grant_id>RETICS RD16/0006/0004 (ARADyAL)</funding_grant_id><funding_grant_id>IB20134</funding_grant_id><funding_grant_id>PI21/01683</funding_grant_id><funding_grant_id>GR21073</funding_grant_id><funding_grant_id>PI18/00540</funding_grant_id><pubmed_authors>Garcia-Martin E</pubmed_authors><pubmed_authors>Garcia-Albea E</pubmed_authors><pubmed_authors>Benito-Leon J</pubmed_authors><pubmed_authors>Jimenez-Jimenez FJ</pubmed_authors><pubmed_authors>Calleja P</pubmed_authors><pubmed_authors>Millan-Pascual J</pubmed_authors><pubmed_authors>Turpin-Fenoll L</pubmed_authors><pubmed_authors>Alonso-Navarro H</pubmed_authors><pubmed_authors>Diaz-Sanchez M</pubmed_authors><pubmed_authors>Gomez-Tabales J</pubmed_authors><pubmed_authors>Agundez JAG</pubmed_authors><pubmed_authors>Plaza-Nieto JF</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association between &lt;i>LAG3/CD4&lt;/i> Genes Variants and Risk for Multiple Sclerosis.</name><description>Several recent works have raised the possibility of the contribution of the lymphocyte activation gene 3 (LAG3) protein in the inflammatory processes of multiple sclerosis (MS). Results of studies on the possible association between &lt;i>LAG3&lt;/i> gene variants and the risk of MS have been inconclusive. In this study, we tried to show the possible association between the most common single nucleotide variants (SNVs) in the &lt;i>CD4&lt;/i> and &lt;i>LAG3&lt;/i> genes (these two genes are closely related) and the risk of MS in the Caucasian Spanish population. We studied the genotypes and allelic variants &lt;i>CD4 rs1922452&lt;/i>, &lt;i>CD4 rs951818&lt;/i>, and &lt;i>LAG3 rs870849&lt;/i> in 300 patients diagnosed with MS and 400 healthy patients using specific &lt;i>TaqMan&lt;/i>-based qPCR assays. We analyzed the possible influence of the genotype frequency on age at the onset of MS, the severity of MS, clinical evolutive subtypes of MS, and the &lt;i>HLADRB1*1501&lt;/i> genotype. The frequencies of the &lt;i>CD4 rs1922452&lt;/i>, &lt;i>CD4 rs951818&lt;/i>, and &lt;i>LAG3 rs870849&lt;/i> genotypes and allelic variants were not associated with the risk of MS and were unrelated to gender, age at onset and severity of MS, the clinical subtype of MS, and &lt;i>HLADRB1*1501&lt;/i> genotype. The results of the current study showed a lack of association between the &lt;i>CD4 rs1922452&lt;/i>, &lt;i>CD4 rs951818&lt;/i>, and &lt;i>LAG3 rs870849&lt;/i> SNVs and the risk of developing MS in the Caucasian Spanish population.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-04T08:00:54.08Z</modification><creation>2025-04-04T08:00:54.08Z</creation></dates><accession>S-EPMC9735634</accession><cross_references><pubmed>36499569</pubmed><doi>10.3390/ijms232315244</doi></cross_references></HashMap>